Literature DB >> 28181265

Differences in the multimodal treatment of gastric cancer: East versus west.

Ashley Russo1, Ping Li1,2, Vivian E Strong1.   

Abstract

There has been a great deal of interest about varying treatment paradigms of gastric cancer in Eastern and Western countries. Differences in tumor biology, screening initiatives, surgical approach, extent of lymphadenectomy, and neoadjuvant versus adjuvant chemotherapy regimens have been studied and documented in the literature. The purpose of this review is to give an updated report on the current status and management differences in the treatment of gastric cancer between Eastern and Western countries.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Eastern; Western; gastric adenocarcinoma; gastric cancer

Mesh：

Year:  2017        PMID： 28181265     DOI： 10.1002/jso.24517

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  32 in total

1.  Propensity score-matched comparison of short-term and long-term outcomes between endoscopic submucosal dissection and surgery for treatment of early gastric cancer in a Western setting.

Authors:  R Bausys; A Bausys; J Stanaitis; I Vysniauskaite; K Maneikis; B Bausys; E Stratilatovas; K Strupas
Journal:  Surg Endosc       Date:  2018-12-03       Impact factor: 4.584

2.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

3.  Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery.

Authors:  Eva Lieto; Gennaro Galizia; Annamaria Auricchio; Francesca Cardella; Andrea Mabilia; Nicoletta Basile; Giovanni Del Sorbo; Paolo Castellano; Ciro Romano; Michele Orditura; Vincenzo Napolitano
Journal:  J Gastrointest Surg       Date:  2017-07-27       Impact factor: 3.452

4.  Less may be more: shifting paradigm toward minimally invasive gastrectomy for locally advanced gastric cancer.

Authors:  Jashodeep Datta; Vivian E Strong
Journal:  Transl Gastroenterol Hepatol       Date:  2019-11-26

5.  Repeat staging laparoscopy for gastric cancer after preoperative therapy.

Authors:  Cornelius A Thiels; Naruhiko Ikoma; Keith Fournier; Prajnan Das; Mariela Blum; Jeannelyn S Estrella; Bruce D Minsky; Jaffer Ajani; Paul Mansfield; Brian D Badgwell
Journal:  J Surg Oncol       Date:  2018-06-07       Impact factor: 3.454

Review 6.  Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.

Authors:  Ankur K Nagaraja; Osamu Kikuchi; Adam J Bass
Journal:  Cancer Discov       Date:  2019-11-14       Impact factor: 39.397

Review 7.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

8.  Comparison of gastric cancer survival after R0 resection in the US and China.

Authors:  Ping Li; Chang-Ming Huang; Chao-Hui Zheng; Ashley Russo; Priyanka Kasbekar; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  J Surg Oncol       Date:  2018-10-17       Impact factor: 3.454

Review 9.  Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective.

Authors:  Zuzanna Pelc; Magdalena Skórzewska; Karol Rawicz-Pruszyński; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

10.  Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer.

Authors:  Miaoquan Zhang; Chao Ding; Lin Xu; Biyi Ou; Shoucheng Feng; Guoqiang Wang; Wei Wang; Yao Liang; Yingbo Chen; Zhiwei Zhou; Haibo Qiu
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.